Menu
Back to User profile » Prof. Dr. Zhenguo Liu
Papers published by Prof. Dr. Zhenguo Liu:
Targeting the D1-N-methyl-D-aspartate receptor complex reduces L-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats
Song L, Zhang ZZ, Hu RG, Cheng J, Li L, Fan QY, Wu N, Gan J, Zhou MZ, Liu ZG
Drug Design, Development and Therapy 2016, 10:547-555
Published Date: 3 February 2016
Roles of Ca2+/calmodulin-dependent protein kinase II in subcellular expression of striatal N-Methyl-D-aspartate receptors in L-3, 4-dihydroxyphenylalanine-induced dyskinetic rats
Gan J, Qi C, Liu Z
Drug Design, Development and Therapy 2015, 9:2119-2128
Published Date: 13 April 2015
The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats
Song L, Yang X, Ma Y, Wu N, Liu Z
Drug Design, Development and Therapy 2014, 8:2173-2180
Published Date: 4 November 2014
Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes
Cai Y, Xu M, Yuan M, Liu Z, Yuan W
International Journal of Nanomedicine 2014, 9:3527-3538
Published Date: 25 July 2014
Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson's disease
Gan J, Qi C, Mao LM, Liu ZG
Drug Design, Development and Therapy 2014, 8:165-173
Published Date: 17 January 2014
Effect of Tianqi antitremor granules on behavioral manifestations and expression of G protein-coupled receptor kinase 6 and β-arrestin1 in levodopa-induced dyskinesia in a rat model of Parkinson's disease
Wu N, Yang X, Song L, Wei J, Liu Z
Drug Design, Development and Therapy 2013, 7:1481-1489
Published Date: 10 December 2013
Advances with microRNAs in Parkinson’s disease research
Ma L, Wei L, Wu F, Hu Z, Liu Z, Yuan W
Drug Design, Development and Therapy 2013, 7:1103-1113
Published Date: 1 October 2013
Long-acting preparations of exenatide
Cai Y, Wei L, Ma L, Huang X, Tao A, Liu Z, Yuan W
Drug Design, Development and Therapy 2013, 7:963-970
Published Date: 5 September 2013
Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine
Hong X, Wei L, Wu F, Wu Z, Chen L, Liu Z, Yuan W
Drug Design, Development and Therapy 2013, 7:945-952
Published Date: 4 September 2013
Intrastriatal injections of KN-93 ameliorates levodopa-induced dyskinesia in a rat model of Parkinson’s disease
Yang X, Wu N, Song L, Liu Z
Neuropsychiatric Disease and Treatment 2013, 9:1213-1220
Published Date: 19 August 2013
Novel preparation method for sustained-release PLGA microspheres using water-in-oil-in-hydrophilic-oil-in-water emulsion
Hong X, Wei L, Ma L, Chen Y, Liu Z, Yuan W
International Journal of Nanomedicine 2013, 8:2433-2441
Published Date: 8 July 2013
NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats
Wu N, Song L, Yang X, Yuan W, Liu Z
Clinical Interventions in Aging 2013, 8:347-352
Published Date: 26 March 2013
Porous microsphere and its applications
Cai Y, Chen Y, Hong X, Liu Z, Yuan W
International Journal of Nanomedicine 2013, 8:1111-1120
Published Date: 15 March 2013
Advances with RNA interference in Alzheimer’s disease research
Chen S, Ge X, Chen Y, Lv N, Liu Z, Yuan W
Drug Design, Development and Therapy 2013, 7:117-125
Published Date: 22 February 2013
Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats
Yang X, Chen Y, Hong X, Wu N, Song L,Yuan W, Liu Z
Drug Design, Development and Therapy 2012, 6:341-347
Published Date: 20 November 2012